Results 241 to 250 of about 116,073,120 (283)

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses. [PDF]

open access: yesEMBO Rep
Feng CH   +15 more
europepmc   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

IL-2 mutein promotes antigen-specific transplant acceptance in mice through expansion of ST2<sup>+</sup> regulatory T cells. [PDF]

open access: yesNat Commun
Ganchiku Y   +13 more
europepmc   +1 more source

Neoadjuvant combined immunotherapy with intratumoral TransCon TLR7/8 Agonist and systemic TransCon IL-2 β/y or pembrolizumab in patients with locally advanced oral cancer-a monocentric experience. [PDF]

open access: yesCancer Immunol Immunother
Weber M   +11 more
europepmc   +1 more source

Simultaneous TCR and IL-2 agonism selectively enhances epitope-specific CD8 T-cell responses during chronic viral infection. [PDF]

open access: yesJ Virol
Hashimoto M   +10 more
europepmc   +1 more source

Co-Expression of IL-2 Enhances the Efficacy of FLT3-CAR-γδT Cells in Acute Myeloid Leukemia. [PDF]

open access: yesCancers (Basel)
Wang X   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy